| Literature DB >> 26180048 |
Xin Wang1, Huahua Sun1, Yixi Zhang1, Chuanjun Liu1, Zewen Liu2.
Abstract
The insect central nervous system (CNS) is the target for many insecticides, and changes in transcript levels could be expected after insecticide applications. In this study, differentially expressed genes in the locust (Locusta migratoria manilensis) CNS in response to imidacloprid treatments at low dose (LD, 10% mortality) and high dose (HD, 80% mortality) were identified. Two nicotine acetylcholine receptor (nAChR) subunits genes and 18 interacting protein genes were regulated at LD, and only one nAChR subunit gene and 11 interacting proteins were regulated at HD. Among the 110 annotated P450 unigenes, 43 unigenes were regulated at LD and 34 unigenes were regulated at HD. Most of the differentially expressed P450 unigenes were mapped to CYP4, in which most unigenes were upregulated at LD, but downregulated at HD. Totally, the numbers and regulation levels of the regulated genes were more at LD than that at HD. Seventeen unigenes were selected to test their expression changes following insecticide treatments by qRT-PCR, in which the changes in more than half of the selected genes were verified. The results revealed the variation in the response of locusts to different insecticide pressure, such as different doses.Entities:
Keywords: Locusta migratoria manilensis; P450; imidacloprid; interacting protein; nAChR
Mesh:
Substances:
Year: 2015 PMID: 26180048 PMCID: PMC4677498 DOI: 10.1093/jisesa/iev080
Source DB: PubMed Journal: J Insect Sci ISSN: 1536-2442 Impact factor: 1.857
The specific primers used in qRT-PCR
| Unigene ID | Putative annotation | Primers |
|---|---|---|
| CL2087-1 | CYP6AM1 | F—ATCGACTACACTTACTGGAA |
| R—GAGTAAATACCGACGAAATC | ||
| U5019 | CYP4G43 | F—GCCTTCTTGGACCTTATG |
| R—GTCCTGAATGTCCTGATG | ||
| CL2702-3 | CYP6BK17 | F—CTCGACAAGGTCGTCTCAGAGACG |
| R—GAAGTAGTGAGGGTCGTGATGGAG | ||
| U33624 | Protein kinase C | F—CCTGAATGGTGGAGATCTGATG |
| R—GCGGATATGGCCTTCATAGTC | ||
| CL2319-1 | Mito 12A2 | F—GTTCGCCGAGCTAGAGGTCTAC |
| R—GTCTCTGTCGATGACCTTGAAC | ||
| U13389 | CYP4C1 | F—CAAACGTGAAGATCGATTGCGC |
| R—GGGTGAAGGAAGGCATACATAC | ||
| CL2611-1 | CYP4C1 | F—CAGGATCAGTGAACTCACCATG |
| R—CTTGGATTGGGCTCCGTTCG | ||
| U21296 | Spectrin alpha chain | F—GAACCTGTTGAGCGTGTTGAGGAG |
| R—CATCCTCCCTTCGAACATTCCACC | ||
| U29431 | Spectrin alpha chain | F—ATCTATGATGGAAGGTTCTG |
| R—CTGTGCTCTGTATACCTATT | ||
| CL4026-1 | CYP6AM1 | F—AAAGCTATTTCACTCTGGAG |
| R—TTCAGTACCTCGTCTATCTC | ||
| U6027 | CYP4C1 | F—CACCTACGTCATGCTCTACA |
| R—AGTAATGAGGTCGCTGCTAC | ||
| CL2853-2 | CYP4C62 | F—CCGATGTTCAGGAGAAGGCATAC |
| R—CGTAAGCGTACGGCCTATGAAAG | ||
| U31578 | Mito 2U1 | F—CTGATATACACGGCGCACCACC |
| R—GACAGAGATGGGAGTGAGAGTCC | ||
| U31293 | Mito 302A1 | F—GCAGGGACTGTGGTTGTCACACAG |
| R—GAGCGATACAGCTGCGTGGTCCATG | ||
| CL181-1 | Dynamin 1 | F—ACTAAGGTTCCTGTGGGAGATC |
| R—CATCTGGATCAACACTCTTGGC | ||
| U38505 | CYP4D2 | F—CTGCACTTCTGGCGCAAGATGC |
| R—GTCACGTACTCGTCGCGCTC | ||
| CL3168-1 | Nlα8 | F—CAACTACGAGGTGACGCTGATG |
| R—CCGTTGTAAGTCCACGATCCAA | ||
| β-actin | β-actin | F—CGAAGCACAGTCAAAGAGAGGTA |
| R—GCTTCAGTCAAGAGAACAGGATG | ||
| GAPDH | GAPDH | F—GATGTGAAAGCCGAAGGAAACTG |
| R—GTTGGAGATGACCTTGTAAGAGG |
The expression of nAChR subunits after exposure to imidacloprid
| Name | Unigene ID | Log2Ratio (CK-LD) | Log2Ratio (CK-HD) |
|---|---|---|---|
| CL4363-2 | −0.93 | 0.02 | |
| U7233 | −0.39 | 0.06 | |
| CL3101-1 | −1.75 | −0.41 | |
| CL4363-1 | −1.10 | −0.33 | |
| U4231 | 0.52 | −0.30 | |
| U17972 | 0.27 | 0.24 | |
| CL2382-2 | 0.42 | 0.57 | |
| CL3168-1 | 0.50 | 1.20 | |
| U21252 | −1.26 | 0.02 | |
| U8705 | −8.44 | −2.57 | |
| U4117 | 0.33 | 0.19 | |
| U23042 | −0.66 | −0.42 |
The expression of some nAChR-associated proteins after exposure to imidacloprid
| Name | Unigene ID | Log2Ratio (CK-LD) | Log2Ratio (CK-HD) | Function |
|---|---|---|---|---|
| RIC-3 | U31006 | 1.15 | 1.02 | nAChR maturation ( |
| SAP102 | CL2460-1 | 1.65 | 0.77 | Anchor postsynaptic proteins ( |
| CL2460-4 | 0.94 | 1.02 | ||
| ubiquilin-1 | CL1030-2 | 3.02 | 1.83 | nAChR subunit degradation ( |
| PICK1 | CL1823-1 | 1.34 | 1.10 | Reduce nAChR clusters ( |
| VAMP-1/2 | U16086 | 1.46 | 0.48 | Synaptic vesicle protein ( |
| COP9 signalosome complex subunit 6 | U10234 | 1.22 | 0.52 | interacting with human β1 ( |
| Clathrin heavy chain | CL490-1 | 1.92 | 0.93 | nAChR trafficki ( |
| U545 | 1.86 | 1.20 | nAChR trafficking ( | |
| eEF2 | U17330 | 1.61 | 0.70 | nAChR maturation ( |
| G-protein (Goα) | CL4547-1 | 1.31 | 0.69 | interacting with mouse β2 ( |
| Pyruvate kinase 3 | CL4699-3 | 1.53 | 1.26 | interacting with mouse β2 ( |
| Spectrin alpha chain | U21296 | 2.37 | 2.24 | Cytoskeleton component ( |
| Protein kinase C | U33624 | 3.74 | 2.34 | Serine/threonine phosphorylation ( |
| creatine kinase | CL4483-1 | 1.35 | 0.49 | interacting with mouse β2 ( |
| Dynamin 1 | CL181-1 | −1.30 | −0.72 | nAChR trafficking ( |
| Lysozyme C-1 precursor | CL305-1 | −1.27 | −0.17 | interacting with mouse β2 ( |
| CL3823-2 | −0.42 | 1.82 | ||
| CL691-2 | 4.38 | −0.58 | ||
| 14–3–3 protein | CL1627-1 | 2.45 | 1.27 | nAChR stabilization ( |
| CL1627-3 | −2.20 | −0.56 | ||
| Synaptotagmin | CL2343-1 | 1.67 | 1.31 | interacting with mouse β2 ( |
| CL298-2 | −2.45 | −0.93 |
Numbers of genes encoding P450 proteins whose expression was regulated by imidacloprid treatments
| LD | HD | |||
|---|---|---|---|---|
| Upregulated | Downregulated | Upregulated | Downregulated | |
| CYP4 | 14 | 3 | 7 | 9 |
| CYP6 | 9 | 4 | 7 | 2 |
| CYP9 | 4 | 2 | 3 | 0 |
| Mito | 5 | 2 | 4 | 2 |
| Total | 32 | 11 | 21 | 13 |
The expression variations of 17 unigenes from transcriptome and qRT-PCR analysis
| Unigene ID | LD (transcriptome) | CK | qRT-PCR(LD) | HD (transcriptome) | qRT-PCR(HD) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Log2Ratio (CK-LD) | Fold change | Means | SEM | Means | SEM | Log2Ratio (CK-HD) | Fold change | Means | SEM | |
| CL2087-1 | 4.98 | 31.559 | 1.000 | 0.075 | 7.724 | 1.223** | 2.25 | 4.757 | 6.236 | 0.870** |
| U5019 | 4.45 | 21.857 | 1.000 | 0.039 | 3.311 | 0.498** | 3.90 | 14.929 | 5.557 | 1.144** |
| CL2702-3 | 4.06 | 16.679 | 1.000 | 0.112 | 10.460 | 2.250** | 2.60 | 6.063 | 2.289 | 0.295** |
| U33624 | 3.74 | 13.361 | 1.000 | 0.085 | 5.802 | 1.416** | 2.34 | 5.063 | 3.126 | 0.533** |
| CL2319-1 | 3.32 | 9.987 | 1.000 | 0.058 | 1.265 | 0.181 | 4.10 | 17.148 | 0.983 | 0.112 |
| U13389 | 2.81 | 7.013 | 1.000 | 0.136 | 1.744 | 0.322 | 2.43 | 5.389 | 1.138 | 0.116 |
| CL2611-1 | 2.77 | 6.821 | 1.000 | 0.102 | 4.123 | 0.710** | 2.34 | 5.063 | 2.790 | 0.428** |
| U21296 | 2.37 | 5.169 | 1.000 | 0.071 | 0.112 | 0.042** | 2.24 | 4.724 | 0.308 | 0.060** |
| U29431 | 1.12 | 2.173 | 1.000 | 0.065 | 0.470 | 0.086** | 0.59 | 1.505 | 1.117 | 0.085 |
| CL4026-1 | −7.30 | 0.006 | 1.000 | 0.032 | 0.029 | 0.007** | −1.92 | 0.264 | 0.359 | 0.048** |
| U6027 | −3.69 | 0.077 | 1.000 | 0.114 | 0.016 | 0.004** | −1.42 | 0.374 | 0.812 | 0.071 |
| CL2853-2 | −3.50 | 0.088 | 1.000 | 0.070 | 0.325 | 0.042** | −2.64 | 0.160 | 0.283 | 0.054** |
| U31578 | −1.81 | 0.285 | 1.000 | 0.072 | 1.144 | 0.118 | −1.21 | 0.432 | 0.952 | 0.117 |
| U31293 | −1.71 | 0.306 | 1.000 | 0.056 | 1.113 | 0.095 | −2.52 | 0.174 | 0.864 | 0.093 |
| CL181-1 | −1.30 | 0.406 | 1.000 | 0.064 | 2.029 | 0.530** | −0.72 | 0.607 | 1.090 | 0.125 |
| U38505 | 0.98 | 1.972 | 1.000 | 0.103 | 0.403 | 0.061** | −2.92 | 0.132 | 0.272 | 0.046** |
| CL3168-1 | 0.50 | 1.414 | 1.000 | 0.085 | 0.957 | 0.122 | 1.20 | 2.297 | 0.886 | 0.069 |
* Significantly different at 0.05 level; **significantly different at 0.01 level.
Fig. 1.The fold change in expression level of 17 unigenes between different dose treatments (LD and HD) and CK determined by qRT-PCR. The expression levels in LD and HD were normalized to that in CK. Values are plotted as means ± SE of at least three repeats. *Significantly different at 0.05 level; **Significantly different at 0.01 level.